AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2024-01-13 ms3000001888446951 来自山东省

11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们

12 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2024-01-17 ms6000001348023585 来自河南省

11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们

16 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2023-10-20 ms4000000605372441 来自广西

偏重的研究方向：代谢
经验分享：10月19日投，期待好消息

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2019-02-24 打豆豆d d d

非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。

199 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2017-12-26 嘿嘿嘿嘿嘿

审稿速度:1.0 | 投稿命中率:50.0
经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。

365 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2021-11-24 ms2000000516564288

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：糖尿病
经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

什么是correspondingauthor/通讯作者？

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

期刊可以有几个通讯作者/第一作者？

52 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2021-11-10 ms3000001724764627

收meta不

65 0

[GetPortalCommentsPageByObjectIdResponse(id=2181303, encodeId=625a21813037e, content=11.23投的，已经50天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=367e8128228, createdName=ms3000001888446951, createdTime=Sat Jan 13 15:49:42 CST 2024, time=2024-01-13, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2182207, encodeId=a5c8218220e60, content=11.20投的，已经55天了，一直显示Manuscript Under Review，这合理吗朋友们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db9012317, createdName=ms6000001348023585, createdTime=Wed Jan 17 15:55:17 CST 2024, time=2024-01-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2163939, encodeId=bd54216393962, content=偏重的研究方向：代谢 经验分享：10月19日投，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89848849020, createdName=ms4000000605372441, createdTime=Fri Oct 20 11:58:29 CST 2023, time=2023-10-20, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=567201, encodeId=5e4056e201ea, content=非常好的杂志，编辑非常nice 有责任心，一审24周左右大修，二审3周左右小修，三审一天小修，四审一天接收。加上补实验时间，从投稿到接收大概三个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Sun Feb 24 00:00:00 CST 2019, time=2019-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550356, encodeId=7e3955035616, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常好的杂志，编辑很负责，不完全以审稿人的意见为最终意见，会有自己的判断，时间很准时一个月，以后会多投投这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe31937832, createdName=嘿嘿嘿嘿嘿, createdTime=Tue Dec 26 13:13:00 CST 2017, time=2017-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073490, encodeId=2c9710e349041, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：糖尿病 经验分享：AJP-Endo在生理学有非常好的口碑，老牌杂志。9月10号投稿，10月18号审稿结束，给了一个大修的机会（两个审稿人20个问题）。11月20号修回，11月23号接收。主编真的很友好，他有自己的判断和观点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=537f5417133, createdName=ms2000000516564288, createdTime=Wed Nov 24 11:17:52 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086499, encodeId=79da10864995a, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086500, encodeId=001d1086500f2, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068918, encodeId=7cb6106891895, content=收meta不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ee5682437, createdName=ms3000001724764627, createdTime=Wed Nov 10 10:28:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003738, encodeId=489c1003e38e8, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：减重代谢 经验分享：非常nice的编辑，点赞。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8ab5426559, createdName=ms8000000385653095, createdTime=Thu Jul 29 22:57:54 CST 2021, time=2021-07-29, status=1, ipAttribution=)]

2021-07-29 ms8000000385653095

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：减重代谢
经验分享：非常nice的编辑，点赞。

60 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务